NIDA - Research Monographs - Monograph 113: Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment

[Finished Printing? - Click Here to Return to Normal View]

	NIDA Home > Publications > Research Monographs >
	Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment

NIDA Research Monograph, Number 113 [Printed in 1991]

If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph113.pdf - Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment (1 MB)

Table of Contents

Introduction

Introduction and Summary-----1
William S. Cartwright and James M. Kaple

Economic Costs of Drug Abuse

Economic Costs of Drug Abuse-----10
Dorothy P. Rice, Sander Kelman, and Leonard S. Miller

Economic Cost of Illicit Drug Studies: Critique and Research Agenda-----33
Jody L. Sindelar

Economics and Drugs: Promises, Problems, and Prospects-----46
Henrick J. Harwood

Cost-Effectiveness Analysis

Evaluating the Cost-Effectiveness of Drug Abuse Treatment Services-----57
Robert Apsler

Cost-Effectiveness of Drug Abuse Treatment: Relevant Issues and Alternative Longitudinal Modeling Approaches-----67
Yih-lng Hser and M. Douglas Anglin

New Perspectives on the Benefit-Cost and Cost-Effectiveness of Drug Abuse Treatment-----94
Robert L. Hubbard and Michael T. French

Cost-Effectiveness of Drug Abuse Treatment for Primary Prevention of Acquired lmmunodeficiency Syndrome: Epidemiologic Considerations-----114
Thomas M. Lampinen

Financing Services for Drug Abuse Treatment

Policy-Relevant Research on Drug Treatment-----129
Dean R. Gerstein

Community-Based Drug Treatment Reimbursement: Progress and Barriers-----148
Benjamin C. Duggar

Financing Treatment for Substance Abuse-----165
Mark V. Pauly

Forecasting the Cost of Drug Abuse Treatment Coverage in Private Health Insurance-----175
Thomas G. McGuire and Barbara F. Shatkin

Health Insurance Coverage Questions, Public Health Surveys, and Drug Abuse-----190
William S. Cariwright and Albert M. Woodward

Recommendations

Recommendations-----205
William S. Cartwright and James M. Kaple

List of NIDA Research Monographs 212

Advanced Search \| FAQs \| Accessibility \| Site Map \| Help \| NIDA Home \| Privacy Policy \| FOIA (NIH) \| Employment \| Print Version
	The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 18, 2002.